Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult subjects (\> 18 years) of either gender with an metacarpophalangeal joint contracture and a palpable cord of \> 20 degrees of a digit (excluding the thumb) due to Dupuytren's contracture~Exclusion Criteria:~* Any subject who has had prior surgical, percutaneous needle aponeurotomy or Xiaflex treatment for Dupuytren's contracture.~* Any subject using anti-coagulant therapy other than low dose aspirin (up to 150mg/day).~* Any subject in the opinion of the MD investigators with chronic, severe or terminal medical illness which would make them unsuitable for study participation.~* Any subject with known allergy to Xiaflex (Clostridial collagenase).~* Any subject who cannot conform to the study visit schedule

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Day 1 manipulation (Type: ACTIVE_COMPARATOR): Finger manipulation one day following Clostridial collagenase injectable
- Day 2 manipulation (Type: ACTIVE_COMPARATOR): Finger manipulation two days following Clostridial collagenase injectable
- Day 4 manipulation (Type: ACTIVE_COMPARATOR): Finger manipulation four days following Clostridial collagenase injectable

Based on this trial design, predict the completion outcome and termination type (if applicable).